1 week Bioventus (BVS) Q4 Earnings and Revenues Surpass Estimates Zacks

Bioventus (BVS) delivered earnings and revenue surprises of 66.67% and 5.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?